BREYANZI is a prescription medicine used to treat large B cell lymphoma, a type of non-Hodgkin lymphoma, when:

  • your first treatment has not worked or your cancer returned within a year of your first treatment OR...Read more

This website is best viewed using the horizontal display on your tablet device.

This website is best viewed using the vertical display on your mobile device.

Personalized therapy requires personalized support

Cell Therapy 360®: Your partner throughout the CAR T cell therapy journey

Cell Therapy 360 offers assistance programs for you and your care partner that are designed to support you throughout treatment and the initial post-infusion monitoring period (at least 4 weeks).

The services and support programs offered through Cell Therapy 360 are available only to people who are receiving a CAR T cell therapy from Bristol Myers Squibb, such as Breyanzi. Certain restrictions and eligibility requirements apply.

Are you caring for someone receiving Breyanzi CAR T cell therapy?
Learn about your important role as a care partner.